Plasma Fractionation Market worth USD 48.55 Billion by 2027, Exhibiting a CAGR of 7.6% | Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Fortune Business Insights™

Key Players Covered in the Plasma Fractionation Market Research Report are CSL, Grifols, S.A, Baxter, Kedrion S.p.A, Octapharma, Shire, Biotest AG, LFB and other key market players

Pune, India, Oct. 29, 2021 (GLOBE NEWSWIRE) — The global plasma fractionation market size is expected to reach USD 48.55 billion by 2027, exhibiting a CAGR of 7.6% during the forecast period. The growing incidence of immunological disorders is expected to spur demand for the market, states Fortune Business Insights, in a report, titled “Plasma Fractionation Market Size, Share & COVID-19 Impact Analysis, By Product (Immunoglobulin, Albumin, Coagulation Factors, Protease Inhibitors, and Others), By Application (Immunology & Neurology, Hematology, Critical Care, Pulmonology, and Others), By End-user (Hospitals & Clinics,  Clinical Research Laboratories, and Others), and Regional Forecast, 2020-2027.” The market size stood at USD 25.44 billion in 2019.

The coronavirus incidence has caused severe damage and financial ruin to industries across the globe. The governments of several countries have instigated lockdown to thwart the spread of this deadly virus. Such plans have caused disturbances in the production and supply chain. But, with time and resolution, we will be able to combat this stern time and get back to normality. Our well-revised reports will help companies to receive in-depth information about the present scenario of every market so that you can adopt the necessary strategies accordingly.

Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/plasma-fractionation-market-101614

Notable Development:

October 2018: Shire announced the commencement of the plasma fractionation facility in Georgia, U.S.

Rising Plasma Application in COVID-19 Recovery to Aid Growth

The COVID-19 outbreak has led to an extensive study of plasma therapy in the development of antidote. The surging cases around the world have made it precedent to discover a vaccine against the virus. The use of blood plasma therapy in the recovery of patients has delivered promising results. Hence, the increased use of plasma in disease management is likely to aid the expansion of the market.

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market. Furthermore, the report offers a detailed analysis and information as per Pharmaceuticals Market Growth Analysis by manufacturers, market segments helping our readers to get a comprehensive overview of the global market. Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market.

For more information in the analysis of this report, visit:
https://www.fortunebusinessinsights.com/industry-reports/plasma-fractionation-market-101614

Report Scope & Segmentation

Amidst this crisis, Fortune Business Insights™ is continuously assessing the impact of COVID-19 pandemic on various sub-markets and is enabling the global organizations to strategize for the post-COVID-19 world to sustain growth. Let us know if you would like to assess the impact of COVID-19 on any industry here- https://www.fortunebusinessinsights.com/healthcare-industry

High R&D for Alzheimer’s Therapies to Contribute Growth

The growing adoption of immunoglobulin for the management, treatment, and diagnosis of metabolic diseases is expected to have a tremendous impact on the market. The ongoing R&D investments and study of immunoglobulin to treat Alzheimer’s and other autoimmune disorders therapies will spur business opportunities for the market.  Immunoglobulin is glycoprotein molecules that are derived by plasma fractionation and act as antibodies. Moreover, the growing utilization of immunoglobulin owing to its superior advantages can further incite the development of the market.

Favorable Government Regulations to Propel Market in North America

The market size in North America is expected to grow profoundly during the forecast period owing to the increasing research and development in the field of plasma. The well-established healthcare infrastructure. The favorable government regulations and FDA approvals are expected to enable speedy expansion of the market in the forthcoming years. 

The growing participation in plasma donations is expected to foster the healthy growth of the market. Europe is predicted to witness high growth during the forecast period due to the growing prevalence of rare diseases in the region. The heavy investments in plasma fractionation systems will create lucrative business opportunities for the market.

Quick Buy Plasma Fractionation Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101614

The Report Lists the Main Companies in this Market:

• CSL
• Grifols, S.A
• Baxter
• Kedrion S.p.A
• Octapharma
• Shire
• Biotest AG
• LFB
• Other Prominent Players

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/plasma-fractionation-market-101614

Table of Content:

• Introduction
  • Research Scope
  • Market Segmentation
  • Research Methodology
  • Definitions and Assumptions
• Executive Summary
• Market Dynamics
  • Market Drivers
  • Market Restraints
  • Market Opportunities
• Key Insights
  • Number of Plasma Collection Centers for Key Countries
  • Recent Industry Developments – Partnerships, Mergers & Acquisitions
  • Regulatory Scenario by Key Countries
  • Prevalence of Chronic Diseases (Key Indications) by Key Countries
  • Impact of COVID-19 Pandemic of Plasma Fractionation Market
• Global Plasma Fractionation Market Analysis, Insights and Forecast, 2016-2027
  • Key Findings / Summary
  • Market Analysis, Insights and Forecast – By Product Type

• • • Albumin
    • Immunoglobulin
      • Intravenous Immunoglobulin
      • Subcutaneous Immunoglobulin
    • Coagulation Factors
      • Factor IX
      • Factor VIII
      • Prothrombin Complex Concentrates
      • Fibrinogen concentrates
      • Others
    • Protease Inhibitors
    • Others

• • Market Analysis, Insights and Forecast – By Application

• • • Immunology & Neurology
    • Hematology
    • Critical Care
    • Pulmonology
    • Others

• • Market Analysis, Insights and Forecast – By End User

• • • Hospitals & Clinics
    • Clinical Research Laboratories
    • Others (Academic Institutes, etc.)

• • Market Analysis, Insights and Forecast – By Region

• • • North America
    • Europe
    • Asia pacific
    • Latin America
    • Middle East & Africa

TOC Continued…!!

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/plasma-fractionation-market-101614

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com